1990•PubMedRequires access

[The value of lysinopril in cardiac insufficiency].

M. Lambert, Roger Luccioni

Open publisher page 0 citations

Abstract

Owing to its original pharmacokinetic profile, lisinopril can be taken once a day, independently of meals, providing a 24-hour inhibition of the angiotensin-converting enzyme. Lisinopril is a potent angiotensin-converting enzyme inhibitor. Administered in doses of 2.5 to 20 mg per day, it improves the functional and haemodynamic state of patients whose congestive heart failure is refractory to the digitalis-diuretic treatment. The drug is well tolerated, and no severe side-effects have been reported. Lisinopril seems to be at least as effective as captopril in congestive heart failure, and it has over the latter the advantage of a once a day dosage therapy.

About this research paper

What this paper is about

Owing to its original pharmacokinetic profile, lisinopril can be taken once a day, independently of meals, providing a 24-hour inhibition of the angiotensin-converting enzyme. Lisinopril is a potent angiotensin-converting enzyme inhibitor. Administered in doses of 2.5 to 20 mg per day, it improves the functional and haemodynamic state of patients whose congestive heart failure is refractory to the digitalis-diuretic treatment. The drug is well tolerated, and no severe side-effects have been reported. Lisinopril seems to be at least as effective as captopril in congestive heart failure, and it has over the latter the advantage of a once a day dosage therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Owing to its original pharmacokinetic profile, lisinopril can be taken once a day, independently of meals, providing a 24-hour inhibition of the angiotensin-converting enzyme. Lisinopril is a potent angiotensin-converting enzyme inhibitor. Administered in doses of 2.5 to 20 mg per day, it improves the functional and haemodynamic state of patients whose congestive heart failure is refractory to the digitalis-diuretic treatment. The drug is well tolerated, and no severe side-effects have been reported. Lisinopril seems to be at least as effective as captopril in congestive heart failure, and it has over the latter the advantage of a once a day dosage therapy.

Key concepts: Lisinopril, Captopril, Heart failure, Digitalis, Angiotensin-converting enzyme, Diuretic, Medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
[The value of lysinopril in cardiac insufficiency]. — Research Paper | ScholarLens